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10,054 in 2005 to 8,751 in 2009 (p0.001). IC proce-
dures also fell from 123,643 in 2005 to 106,202 in
2009 (p0.001). In 2009, the presence of an AMC in a
HRR was linked to 46.3% fewer CAS procedures (IRR
0.537, 95% CI: 0.464-0.622) compared to HRR without
AMC. Higher CEA rates were also linked to fewer CAS
(IRR0.755, 95% CI: 0.687-0.829), while higher rates of
IC and IR procedures were associated with more CAS
(IRR1.028, 95% CI 1.021-1.036; IRR1.083, 95% CI
1.067-1.099).
Conclusions: Total carotid revascularization volume is
falling in CA. Increased use of CAS in a HRR is associated
with fewer CEA, the absence of an AMC, and increased
rates of IC and IR procedures.
Predictors for CAS usage in a California HRR: 2009
HRR Variable
Incidence
Rate
Ratio
95%
Confidence
Interval P value
Average rate
per 10,000
inhabitants
CEA rate 0.755 0.687-0.829 0.001 2.59
IC rate 1.028 1.021-1.036 0.001 31.61
IR rate 1.083 1.067-1.099 0.001 8.21
Presence of an AMC 0.537 0.464-0.622 0.001 N/A
Trends in CEA, CAS, and IC in California: 2005-2009
Year 2005 2006 2007 2008 2009
Carotid Artery Stenting
(CAS) 1,351 1,826 1,297 1,276 1,324
Carotid
Endarterectomy
(CEA) 8,703 8,225 8,151 8,070 7,427
Total Carotid
Revascularization
Procedures 10,054 10,051 9,448 9,346 8,751
Interventional
Cardiology
Procedures (IC) 123,643 120,317 112,192 110,250 106,202
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Objectives: To evaluate the impact of carotid plaque
type and best medical treatment (BMT) on recurrent ca-
rotid stenosis and future cardiovascular events(CVE) fol-
lowing carotid endarterectomy (CEA).
Methods: A retrospective evaluation of long-term col-
lected data was performed. A total of 559 patients with
no-patch CEAwere included in the study (645 operations).
The patients were divided into two groups, Group A: 305
patients (1990- 1999) receiving only ASA and Group B:
254 patients (2000-2009) receiving current BMT, includ-
ing statins. Patients were evaluated with color duplex at 1
and then every 6 months for the first 5 years and annually
thereafter. Mean duration of follow-up was 84 months
(range: 12-228). 11 patients (2%) were lost to follow-up.
Restenosis, CVE (stroke, myocardial infarction) and deaths
were recorded and analyzed with regard to the conven-
tional risk factors, use of statins and the ultrasonographic
characteristics of the plaques. Statistical analysis was per-
formed using Kaplan-Meier and Cox regression analysis.
Results: Freedom from restenosis 50% at 5, 10 and
15 years of follow-up was 93%, 83% and 69% respectively.
Patients with echolucent plaques (types I and II) had a
significantly higher restenosis rate compared to those with
echogenic plaques (types III and IV) at 5 (P0.05), 10 and
15 years (P0.001). Restenosis was also associated with
coronary artery disease (P0.001), diabetes mellitus
(P0.05) and no-statin use (Group A vs Group B,
P0.05). CVEs rate at 5, 10 and 15 years was 17%, 27%
and 38% respectively. Patients with echolucent plaques had
a higher incidence of CVE at 10 and 15 years (P0.001)).
Cardiovascular events were also associated with coronary
artery disease (P0.05), hypertension (P0.05) and no-
statin use (Group A vs Group B, P0.05).
Conclusions: Echolucent carotid plaques, coronary
artery disease and no-statin use are strong predictors of
restenosis and future CVE following CEA.
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Objectives: The aim of this study was to investigate the
accuracy of CT angiography (CTA), MR angiography
(MRA), and digital subtraction angiography (DSA) in
grading of carotid stenosis compared with actual measure-
ment of luminal area reduction in an in vitro model.
JOURNAL OF VASCULAR SURGERY
June Supplement 201152S Abstracts
Methods: Various grades of stenosis were created by
adhering different amounts of silicone rubber sealant onto
the inner wall of clear, radiolucent tubes. Following CTA,
MRA and DSA, the tubes were transected with 1-mm
interval through the plaques. The cross-sectional areas were
digitally photographed, and the percentage of area reduc-
tion of every single slide was measured using ImageJ plani-
metric software (Figure 1). The maximum actual area re-
duction (AAR) stenosis of each tube was recorded. The
differences among CTA, MRA, DSA, and AAR were com-
pared statistically.
Results: Overall, CTA andMRA significantly underes-
timated the degrees of stenosis compared with AAR
(p0.001 and p0.0009, respectively), and no significant
difference between DSA and AAR (p3.98). In the sub-
group with stenosis less than 70%, there was no significant
difference between CTA, MRA, and DSA versus AAR
(p0.16, p0.08, and p1.76, respectively). In the sub-
group with severe stenosis over 70%, CTA and MRA sig-
nificantly underestimated the stenosis versus AAR
(p0.004, and p0.007 respectively); and DSA signifi-
cantly overestimated the stenosis (p0.0007).
Conclusions: CTA, MRA, and DSA are consistent
with AAR in grading of mild to moderate stenosis. CTA
and MRA significantly underestimate, but DSA signifi-
cantly overestimates the percentages of severe stenotic le-
sions. Morphology of carotid plaques may affect the accu-
racy of imaging studies. Clinical correlation need to be
investigated.
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Objectives: Post-procedure microembolization dem-
onstrated on diffusion weighted MRI (DWI) has emerged
into a promising outcome measure for carotid interven-
tions. We previously demonstrated that technical modifica-
tions to our carotid stenting (CAS) program can reduce
microembolization. We sought to examine the impact of
these modifications on the incidence of microemboli in
patients who receive carotid revascularization procedures.
Methods: From 7/2004 to 6/2010, a total of 228
consecutive patients (143 CEA and 85 CAS) who under-
went carotid interventions also received pre- and post-
operative MRI evaluations in a single academic institution.
Prior to January 2007 (Period1) 41 patients underwent
CAS. After January 2007 (Period2), CAS was performed
using a closed-cell system, early heparinization, minimal
arch manipulation, and involvement of experienced physi-
cians. Hospital records for all patients were reviewed for
comorbidities, lesion characteristics, procedural informa-
tion, postoperative outcomes, and incidence of postproce-
dural microemboli.
Results: Forty (47%) CAS patients compared to 15
(10%) CEA patients had acute microemboli on postproce-
dural DWI (P0.001), and also had a higher incidence of
contralateral microembolization (P0.01,OR6). In Pe-
riod1 the incidence of microemboli in CAS patients was
59%, and in Period2 it was reduced to 36% (P0.01).
Multivariant analysis demonstrated that the strongest pre-
dictors of microembolization after CAS or CEA were
BMI30 (P0.001,OR11), history of coronary artery dis-
ease (P0.027,OR5), or the detection of infarcts on pre-
operative MRI, (P0.006,OR8).
Conclusions: Although the incidence of microembolic
events following CAS is higher compared to CEA, proce-
dural modifications to CAS along with appropriate patient
selection can help significantly decrease its occurrence.
Further investigational use of periprocedural DWI is
needed to determine the utility and cost-effectiveness of
identifying patients at risk of microembolic events.
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Objectives: The current Center for Medicare and
Medicaid Services (CMS) guidelines offer stenting as an
alternative largely in symptomatic patients with high-grade
stenosis considered “high risk” for carotid endarterectomy
(CEA).We stratified patients who underwent carotid artery
stenting (CAS) by CMS inclusion criteria and compared
their outcomes.
Methods: A retrospective chart review of all CAS pro-
cedures from 2001 through 2010 at our institution was
performed. Patients were identified using the SVS Registry
and electronic hospital records using ICD-9 codes and
stratified according to CMS risk factors. Data analysis in-
cluded multivariate logistic regression using physiologic
high-risk status, anatomic high-risk status, symptom status,
and gender as predictors. Combined 30-day CVA/TIA,
death, or MI served as the primary outcome.
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